Moderate-dose cyclophosphamide in the treatment of relapsed/refractory T-cell large granular lymphocytic leukemia-associated pure red cell aplasia | |
Peng, Guangxin; Yang, Wenrui; Zhang, Li; Zhou, Kang; Li, Yang; Li, Yuan; Ye, Lei; Li, Jianping; Fan, Huihui; Song, Lin | |
2016 | |
卷号 | 21期号:3页码:138-143 |
关键词 | T-cell large granular lymphocyte leukemia Cyclophosphamide Cyclosporine A Pure red cell aplasia |
ISSN号 | 1024-5332 |
DOI | 10.1080/10245332.2015.1101977 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6382093 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Peng, Guangxin,Yang, Wenrui,Zhang, Li,et al. Moderate-dose cyclophosphamide in the treatment of relapsed/refractory T-cell large granular lymphocytic leukemia-associated pure red cell aplasia[J],2016,21(3):138-143. |
APA | Peng, Guangxin.,Yang, Wenrui.,Zhang, Li.,Zhou, Kang.,Li, Yang.,...&Jing, Liping.(2016).Moderate-dose cyclophosphamide in the treatment of relapsed/refractory T-cell large granular lymphocytic leukemia-associated pure red cell aplasia.,21(3),138-143. |
MLA | Peng, Guangxin,et al."Moderate-dose cyclophosphamide in the treatment of relapsed/refractory T-cell large granular lymphocytic leukemia-associated pure red cell aplasia".21.3(2016):138-143. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论